Gilead Sciences Inc. (NASDAQ: GILD) announced the completion of its acquisition of Tubulis GmbH, a Germany-based biotechnology company developing antibody-drug ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Mergers and Acquisitions